As per Data Bridge Market Research Analysis the global splice-modulating drug market size was valued at USD 964.00 million in 2025 and is expected to reach USD 4,200.61 million by 2033, at a CAGR of 20.20% during the forecast period
The market growth is largely fueled by the increasing advancements in RNA-targeted therapeutics and growing research focus on gene expression regulation, leading to expanded applications across oncology and rare genetic disorders
Furthermore, rising demand for precision medicine and targeted treatment approaches, along with increasing clinical success of antisense oligonucleotides and small molecule splicing modifiers, is establishing splice-modulating drugs as a transformative therapeutic class. These converging factors are accelerating the adoption of splice-modulating therapies, thereby significantly boosting the industry's growth